ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1444

Validation of a Revised Version of the Michigan Body Map

Chad Brummett1, Rishi Bakshi2, Daniel Leung1, Jennifer Zollars3, Jenna Goesling1, Stephanie Moser4, David A. Williams5 and Afton L. Hassett6, 1Anesthesiology, University of Michigan, Ann Arbor, MI, 2Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, 3Anesthesiology, University of Michigan Health System, Ann Arbor, MI, 4Department of Anesthesiology, University of Michigan, Ann Arbor, MI, 5Anesthseiology, University of Michigan, Ann Arbor, MI, 6Anesthesiology, University of Michigan Medical School, Ann Arbor, MI

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: measure and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pain: Basic and Clinical Aspects Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Title: Validation of a
Revised Version of the Michigan Body Map

Background/Purpose:

One of the hallmark features of fibromyalgia and other
centralized pain states is widespread body pain.  We developed the original Michigan Body Map
(MBM) as a self-report measure to assess widespread body pain in clinical care
and in epidemiological studies (Fig 1a). 
It is a one-sided body image with check boxes for 35 body areas and a
box for “No Pain.”  Whereas patients
preferred the original MBM to the Widespread Pain Index used to describe the body
areas for the 2011 Survey Criteria for Fibromyalgia (FM), there were some
issues with distinguishing left from right side body areas and some preferred
the two-sided image from the Brief Pain Inventory. We developed a new body map
(Fig 1b) that consists of the same 35 body areas, but is a two-sided image depicting
front and back. The aim of the present study was to assess patients’
understanding of and accuracy when completing the new MBM, as well as to assess
preference when compared to the original MBM.

Methods:

80 patients from the University of Michigan’s Physical
Medicine and Rehabilitation Spine Center were included in this study.  Written informed consent was obtained. Patients
completed both the original MBM and the new MBM. Order of completion was
counterbalanced across participants. Understanding, accuracy and preference
between the two body maps were assessed.

Results:

Participants completed the original body map (34.5 sec) more
quickly than the new map (44 sec) (p = 0.003).  Compared to the original map, the new map was more
frequently preferred, better allowed participants to show pain, and was easier
to accurately show painful areas on left and right sides (Table 1).   12 (15%) participants incorrectly flipped
left and right sides on the original MBM compared to only 4 (5%) participants
on the new MBM (p = .046). Participants incorrectly endorsed an average of 2.5
body areas on the original body map compared to only 1.6 on the new map (p = 0.004).
 No
differences were found in the calculation of the count of 19 body areas used in
the 2011 survey criteria for FM in the original map (4.78 ±3.01) compared to
the new map (4.79 ± 3.3) (p = 0.922).

Conclusion:

Overall, participants demonstrated good understanding of the
new MBM and generally preferred it to the original MBM.  There were no significant differences in the FM
survey scores between the old and new body maps suggesting that data from the
two different versions can be combined when necessary. 


Disclosure: C. Brummett, Tonix Pharmaceuticals, 5; R. Bakshi, None; D. Leung, None; J. Zollars, None; J. Goesling, None; S. Moser, None; D. A. Williams, Health Focus Inc., 5; A. L. Hassett, Bristol-Myers Squibb, 2,Lexicon Pharma, 5.

To cite this abstract in AMA style:

Brummett C, Bakshi R, Leung D, Zollars J, Goesling J, Moser S, Williams DA, Hassett AL. Validation of a Revised Version of the Michigan Body Map [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/validation-of-a-revised-version-of-the-michigan-body-map/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validation-of-a-revised-version-of-the-michigan-body-map/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology